U.S. Markets close in 2 hrs 8 mins

NanoFlu Vaccine Could Be Big Growth Opportunity for Novavax

Margaret Patrick
NanoFlu Vaccine Could Be Big Growth Opportunity for Novavax

Is Novavax an Attractive Pick after First-Quarter Results?(Continued from Prior Part)Nanoflu vaccine updatesOn January 3, Novavax (NVAX) issued a press release announcing positive top-line results from a Phase 2 trial that compared multiple